113 related articles for article (PubMed ID: 25159033)
1. Establishment and validation of new complementing cells for production of E1-deleted adenovirus vectors in serum-free suspension culture.
Gilbert R; Guilbault C; Gagnon D; Bernier A; Bourget L; Elahi SM; Kamen A; Massie B
J Virol Methods; 2014 Nov; 208():177-88. PubMed ID: 25159033
[TBL] [Abstract][Full Text] [Related]
2. Human amniocyte-derived cells are a promising cell host for adenoviral vector production under serum-free conditions.
Silva AC; Simão D; Küppers C; Lucas T; Sousa MF; Cruz P; Carrondo MJ; Kochanek S; Alves PM
Biotechnol J; 2015 May; 10(5):760-71. PubMed ID: 25943527
[TBL] [Abstract][Full Text] [Related]
3. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.
Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M
Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914
[TBL] [Abstract][Full Text] [Related]
4. Protease-deleted adenovirus vectors and complementing cell lines: potential applications of single-round replication mutants for vaccination and gene therapy.
Oualikene W; Lamoureux L; Weber JM; Massie B
Hum Gene Ther; 2000 Jun; 11(9):1341-53. PubMed ID: 10890743
[TBL] [Abstract][Full Text] [Related]
5. A Method to Generate and Rescue Recombinant Adenovirus Devoid of Replication-Competent Particles in Animal-Origin-Free Culture Medium.
Elahi SM; Jiang J; Nazemi-Moghaddam N; Gilbert R
Viruses; 2023 Oct; 15(11):. PubMed ID: 38005830
[TBL] [Abstract][Full Text] [Related]
6. Matching complementing functions of transformed cells with stable expression of selected viral genes for production of E1-deleted adenovirus vectors.
Howe JA; Pelka P; Antelman D; Wilson C; Cornell D; Hancock W; Ramachandra M; Avanzini J; Horn M; Wills K; Sutjipto S; Ralston R
Virology; 2006 Feb; 345(1):220-30. PubMed ID: 16246392
[TBL] [Abstract][Full Text] [Related]
7. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.
Fallaux FJ; Bout A; van der Velde I; van den Wollenberg DJ; Hehir KM; Keegan J; Auger C; Cramer SJ; van Ormondt H; van der Eb AJ; Valerio D; Hoeben RC
Hum Gene Ther; 1998 Sep; 9(13):1909-17. PubMed ID: 9741429
[TBL] [Abstract][Full Text] [Related]
8. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus.
Cheshenko N; Krougliak N; Eisensmith RC; Krougliak VA
Gene Ther; 2001 Jun; 8(11):846-54. PubMed ID: 11423932
[TBL] [Abstract][Full Text] [Related]
9. Development of a suspension serum-free helper-dependent adenovirus production system and assessment of co-infection conditions.
Meneses-Acosta A; Dormond E; Jacob D; Tom R; Bernier A; Perret S; St-Laurent G; Durocher Y; Gilbert R; Kamen A
J Virol Methods; 2008 Mar; 148(1-2):106-14. PubMed ID: 18079009
[TBL] [Abstract][Full Text] [Related]
10. A rapid and sensitive assay for detection of replication-competent adenoviruses by a combination of microcarrier cell culture and quantitative PCR.
Schalk JA; de Vries CG; Orzechowski TJ; Rots MG
J Virol Methods; 2007 Nov; 145(2):89-95. PubMed ID: 17588680
[TBL] [Abstract][Full Text] [Related]
11. Complementary Cell Lines for Protease Gene-Deleted Single-Cycle Adenovirus Vectors.
Elahi SM; Nazemi-Moghaddam N; Guilbault C; Simoneau M; Gilbert R
Cells; 2023 Feb; 12(4):. PubMed ID: 36831286
[TBL] [Abstract][Full Text] [Related]
12. Scalable production of adenovirus vectors.
Silva AC; Fernandes P; Sousa MF; Alves PM
Methods Mol Biol; 2014; 1089():175-96. PubMed ID: 24132486
[TBL] [Abstract][Full Text] [Related]
13. Designing E1 deleted adenoviral vector by homologous recombination.
Zamani A; Ghannad MS
Iran Biomed J; 2007 Jul; 11(3):199-202. PubMed ID: 18051781
[TBL] [Abstract][Full Text] [Related]
14. Development and optimization of an adenovirus production process.
Kamen A; Henry O
J Gene Med; 2004 Feb; 6 Suppl 1():S184-92. PubMed ID: 14978761
[TBL] [Abstract][Full Text] [Related]
15. Helper-dependent adenoviral vectors efficiently express transgenes in human dendritic cells but still stimulate antiviral immune responses.
Roth MD; Cheng Q; Harui A; Basak SK; Mitani K; Low TA; Kiertscher SM
J Immunol; 2002 Oct; 169(8):4651-6. PubMed ID: 12370405
[TBL] [Abstract][Full Text] [Related]
16. A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions.
Wang Q; Jia XC; Finer MH
Gene Ther; 1995 Dec; 2(10):775-83. PubMed ID: 8750018
[TBL] [Abstract][Full Text] [Related]
17. Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells.
Fechner H; Wang X; Wang H; Jansen A; Pauschinger M; Scherübl H; Bergelson JM; Schultheiss HP; Poller W
Gene Ther; 2000 Nov; 7(22):1954-68. PubMed ID: 11127584
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted.
Amalfitano A; Hauser MA; Hu H; Serra D; Begy CR; Chamberlain JS
J Virol; 1998 Feb; 72(2):926-33. PubMed ID: 9444984
[TBL] [Abstract][Full Text] [Related]
19. Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches.
Murakami P; Havenga M; Fawaz F; Vogels R; Marzio G; Pungor E; Files J; Do L; Goudsmit J; McCaman M
J Virol; 2004 Jun; 78(12):6200-8. PubMed ID: 15163713
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal integration pattern of a helper-dependent minimal adenovirus vector with a selectable marker inserted into a 27.4-kilobase genomic stuffer.
Hillgenberg M; Tönnies H; Strauss M
J Virol; 2001 Oct; 75(20):9896-908. PubMed ID: 11559822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
